NZ751591A - Compositions and methods of using islet neogenesis peptides and analogs thereof - Google Patents
Compositions and methods of using islet neogenesis peptides and analogs thereofInfo
- Publication number
- NZ751591A NZ751591A NZ751591A NZ75159114A NZ751591A NZ 751591 A NZ751591 A NZ 751591A NZ 751591 A NZ751591 A NZ 751591A NZ 75159114 A NZ75159114 A NZ 75159114A NZ 751591 A NZ751591 A NZ 751591A
- Authority
- NZ
- New Zealand
- Prior art keywords
- analogs
- peptides
- methods
- compositions
- islet neogenesis
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 230000009707 neogenesis Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000001737 promoting effect Effects 0.000 abstract 2
- 230000008929 regeneration Effects 0.000 abstract 2
- 238000011069 regeneration method Methods 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 101100189458 Mesocricetus auratus INGAP gene Proteins 0.000 abstract 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 208000016097 disease of metabolism Diseases 0.000 abstract 1
- 230000001771 impaired effect Effects 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 230000004112 neuroprotection Effects 0.000 abstract 1
- 230000004203 pancreatic function Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Abstract
The invention provides peptides and analogs of INGAP and HIP peptides. The peptides and analogs can be used in methods for treating various diseases and conditions. Such diseases and conditions can include impaired pancreatic function, treating a metabolic disease, for example, diabetes, both type 1 and type 2 diabetes, islets induction, expansion and proliferation for transplantation, promoting neuroprotection or nerve regeneration, promoting liver regeneration or inhibiting inflammation.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2013/072771 WO2014139182A1 (en) | 2013-03-15 | 2013-03-15 | Compositions and methods of using islet neogenesis peptides and analogs thereof |
| NZ711958A NZ711958A (en) | 2013-03-15 | 2014-03-14 | Compositions and methods of using islet neogenesis peptides and analogs thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ751591A true NZ751591A (en) | 2020-08-28 |
Family
ID=72265404
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ751589A NZ751589A (en) | 2013-03-15 | 2014-03-14 | Compositions and methods of using islet neogenesis peptides and analogs thereof |
| NZ751591A NZ751591A (en) | 2013-03-15 | 2014-03-14 | Compositions and methods of using islet neogenesis peptides and analogs thereof |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ751589A NZ751589A (en) | 2013-03-15 | 2014-03-14 | Compositions and methods of using islet neogenesis peptides and analogs thereof |
Country Status (1)
| Country | Link |
|---|---|
| NZ (2) | NZ751589A (en) |
-
2014
- 2014-03-14 NZ NZ751589A patent/NZ751589A/en unknown
- 2014-03-14 NZ NZ751591A patent/NZ751591A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ751589A (en) | 2020-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019009886A (en) | Compositions and methods of using islet neogenesis peptides and analogs thereof. | |
| PH12020550450A1 (en) | Certain chemical entities, compositions and methods | |
| PH12018500016A1 (en) | Agents, uses and methods for the treatment of synucleinopathy | |
| PH12018500086A1 (en) | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | |
| SG10201809428UA (en) | Insulin receptor partial agonists | |
| GEP20207147B (en) | Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors | |
| SG10201906304TA (en) | Use of perfusion decellularized liver for islet cell recellularization | |
| SG10201902872YA (en) | Ex vivo proliferation of epithelial cells | |
| MX2019005594A (en) | Agents, uses and methods for the treatment of synucleinopathy. | |
| NZ631701A (en) | Apoptosis-including agents for the treatment of cancer and immune and autoimmune diseases | |
| PH12019502646A1 (en) | Pyrazole magl inhibitors | |
| EA033345B1 (en) | TRICYCLIC SULFONES AS RORĪ³ MODULATORS | |
| GB2496337A (en) | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases | |
| MX2018005399A (en) | New polypeptide having affinity to pd-l1. | |
| MX2022015248A (en) | Methods of treating inflammatory diseases. | |
| MX2013000958A (en) | Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma. | |
| BR112017014361A2 (en) | methods for perfecting cell therapy | |
| MX2017014456A (en) | Therapeutic uses of l-4-chlorokynurenine. | |
| MX367858B (en) | Conotoxin peptides, pharmaceutical compositions and uses thereof. | |
| MX371343B (en) | Liver x receptor (lxr) modulators. | |
| PH12019501683A1 (en) | Rorgamma modulators and uses thereof | |
| PH12019501682A1 (en) | Rorgamma modulators and uses thereof | |
| EP3810174A4 (en) | Compositions and methods for propagating insulin-producing islet cells and therapeutic uses thereof | |
| NZ751591A (en) | Compositions and methods of using islet neogenesis peptides and analogs thereof | |
| MX2017003949A (en) | Novel peptide derivatives and uses thereof. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 MAR 2022 BY HENRY HUGHES IP LIMITED Effective date: 20210216 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 MAR 2023 BY HENRY HUGHES IP LIMITED Effective date: 20220208 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 MAR 2024 BY HENRY HUGHES IP LIMITED Effective date: 20230131 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 MAR 2025 BY DENNEMEYER + CO. S.A.R.L. Effective date: 20240304 |